https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=4-HO-DALT
4-HO-DALT - 版本历史
2026-07-18T16:47:33Z
本wiki上该页面的版本历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=4-HO-DALT&diff=4658760&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:32:24Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Infobox drug<br />
| drug_name = <br />
| image = 4-HO-DALT structure.png<br />
| width = <br />
| caption = <br />
<br />
<!-- Clinical data --><br />
| pronounce = <br />
| tradename = <br />
| Drugs.com = <br />
| MedlinePlus = <br />
| licence_CA = <br />
| licence_EU = <br />
| DailyMedID = <br />
| licence_US = <br />
| pregnancy_AU = <br />
| pregnancy_category = <br />
| dependency_liability = <br />
| addiction_liability = <br />
| routes_of_administration = <br />
| class = [[Serotonin receptor agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]]<br />
| ATC_prefix = None<br />
| ATC_suffix = <br />
<br />
<!-- Legal status --><br />
| legal_status = <br />
<br />
<!-- Pharmacokinetic data --><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| metabolites = <br />
| onset = <br />
| elimination_half-life = <br />
| duration_of_action = <br />
| excretion = <br />
<br />
<!-- Identifiers --><br />
| CAS_number = 2173386-70-2<br />
| CAS_supplemental = <br />
| PubChem = 119026031<br />
| PubChemSubstance = <br />
| IUPHAR_ligand = <br />
| DrugBank = <br />
| ChemSpiderID = 52085332<br />
| UNII = 44YV9DEA7I<br />
| KEGG = <br />
| ChEBI = <br />
| ChEMBL = <br />
| NIAID_ChemDB = <br />
| PDB_ligand = <br />
| synonyms = 4-Hydroxy-''N'',''N''-diallyltryptamine; 4-Hydroxy-DALT; 4-OH-DALT; Dalocin<br />
<br />
<!-- Chemical data --><br />
| IUPAC_name = 3-[2-[bis(prop-2-enyl)amino]ethyl]-1''H''-indol-4-ol<br />
| C=16 | H=20 | N=2 | O=1<br />
| SMILES = C=CCN(CCC1=CNC2=C1C(=CC=C2)O)CC=C<br />
| StdInChI = 1S/C16H20N2O/c1-3-9-18(10-4-2)11-8-13-12-17-14-6-5-7-15(19)16(13)14/h3-7,12,17,19H,1-2,8-11H2<br />
| StdInChIKey = JVIWQWJXRKVJTA-UHFFFAOYSA-N<br />
}}<br />
'''{{PAGENAME}}'''（'''4-羟基-''N,N''-二烯丙基色胺'''，{{langx|en|4-hydroxy-''N,N''-diallyltryptamine}}）是一种[[色胺]][[衍生物]]，化学式为[[C16H20N2O|C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O]]，可作为[[迷幻药物]]，最早由[[亚历山大·舒尔金]]在1997年的书《[[TiHKAL]]》中描述<ref name="TiHKAL">CiteTiHKAL: "Another direction possible for modifying the structure would be to relocate the oxygen in indole ring over to the 4-position. 4-Methoxytryptamine is commercially available, and it should be directly substitutable for the 5-methoxytryptamine used in this synthetic process giving rise to 4-MeO-DALT. Yet further out, what about starting the 4-benzyloxytryptamine and walking the same path? The product could be easily stripped of the benzyl ether by the usual catalytic hydrogenation, giving rise to the diallyl analogue of psilocin, 4-HO-DALT. I would wager a ten dollar bet that the acetate ester of this material, 4-AcO-DALT would be in the brain within minutes of swallowing the pill."</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
==外部链接==<br />
* [https://isomerdesign.com/pihkal/explore/5530 4-HO-DALT - Isomer Design]<br />
* [https://www.bluelight.org/xf/threads/713565 The Small & Handy 4-HO-DALT Thread - Bluelight]<br />
<br />
{{色胺}}<br />
<br />
[[Category:策划药]]<br />
[[Category:二烯丙氨基化合物]]<br />
[[Category:致幻色胺]]</div>
imported>Jimmy-bot